Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 26.9219.03-30.24-17.43-10.80

What is the latest Core EBITDA Growth ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Growth ratio of JUBILANT PHARMOVA is 26.92 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202526.92
Mar202419.03
Mar2023-30.24
Mar2022-17.43
Mar2021-10.80

How is Core EBITDA Growth of JUBILANT PHARMOVA Trending?

Years Core EBITDA Growth % Change
Mar2025 26.92
41.46
Mar2024 19.03
Positive
Mar2023 -30.24
Negative
Mar2022 -17.43
Negative
Mar2021 -10.8 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Growth ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹17,923.6 Cr 5.2% 2% 10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,167.0 Cr NA -0.9% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

5.2%

2%

10.5%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses